Company Overview and News

 
Elpro International to sell nearly 1.33 per cent stake in PNB MetLife

2018-05-08 thehindubusinessline
Elpro International has agreed to sell approximately 1.33 per cent shareholding in PNB MetLife India Insurance Company for a total consideration of ₹134.22 crore. The decision is subject to satisfaction of certain conditions, including approval from the Insurance Regulatory and Development Authority of India and the Competition Commission of India. Elpro International has been holding 12.75 per cent stake in PNB MetLife Insurance since 2003.
504000 ELPROINTL 512068 DECNGOLD

 
Avanti Feeds board to mull bonus, stock split

2018-05-08 thehindubusinessline
The board of Avanti Feeds will meet on Wednesday to consider proposals of sub-division of face value of equity shares and issue of bonus shares. If approved, this would be the maiden bonus issue from the food major. Shareholders will closely monitor the ratio for both stock split and bonus. Currently, the public, which include the Thai Union Group, AP Industrial Development Corporation, four alternate investment funds and some 43,000 retail investors, holds 56.
AVANTI 512068 512573 DECNGOLD

2
Eyes on Eicher Motors, Fed Bank, OBC results

2018-05-08 thehindubusinessline
Close to 40 companies will declare their quarter and year-end results for the period ended March 2018 on Wednesday.
523207 JUBILANT 500469 500403 538666 FEDA 530019 MARALOVER 533227 505200 MAGMA AHLEAST ASIANHOTNR FEDS 524000 FEDERALBNK EICHERMOT 523457 AHLWEST ECQRY 521018 LINDEINDIA KOKUYOCMLN 512068 FDBAY 533221 DECNGOLD 532774 SHARDACROP SUNDRMFAST AFL 500023

 
Biosimilar push may boost Lupin

2018-05-08 thehindubusinessline
Drug firm Lupin on Tuesday said its Japanese arm and YL Biologics have submitted a new drug application with the Japanese health regulator PMDA for marketing authorisation of a biosimilar of Etanercept used for treating rheumatoid arthritis at an affordable price.
512068 DECNGOLD

 
Tech sector gains keep world shares near one-week high

2018-05-08 thehindubusinessline
Brent futures nevertheless eased 0.8 per cent after hitting new highs above $75 a barrel and MSCI's world equity index inched a touch higher after two days of gains and having touched one-week highs in the previous session.
512068 DECNGOLD

 
European shares retreat as election woes hit Italy

2018-05-08 thehindubusinessline
European shares retreated on Tuesday amid disappointing corporate earnings and worries over a snap election in Italy that put Milan on track for its worst day since an inconclusive March general election.
512068 DECNGOLD

 
MFs log Rs 1.4 lakh cr inflows in April

2018-05-08 thehindubusinessline
Overall, investors have poured in Rs 1.4 lakh crore in mutual fund schemes last month compared with redemptions of Rs 50,752 crore in March due to long-term equity gains tax.
512068 DECNGOLD

16
Exide shares extend gains on robust net profit

2018-05-08 thehindubusinessline
Goldman Sachs has raised its FY19-20 revenue estimates by an average of 2.4 per cent to factor in robust volumes and lead prices.
EXIDEIND DB 512068 DECNGOLD EXQDY MS 500086

 
TCNS Clothing gets SEBI approval for IPO

2018-05-08 thehindubusinessline
Women’s apparel maker TCNS Clothing Company has received the markets regulator SEBI’s go-ahead to float an initial public offering. TCNS sells its products under the W, Aurelia and Wishful brands. The firm had filed draft papers with the regulator in February and obtained its “observations” on May 4, according to the latest update with the Securities and Exchange Board of India.
512068 DECNGOLD

 
Anarock, ANB Capital to start investment banking advisory service

2018-05-08 thehindubusinessline
Anarock Property Consultants today announced the merger of ANB Capital with itself to start a real estate investment banking advisory service.
512068 DECNGOLD

 
Deccan Gold Mines rallies over 17%

2018-05-08 thehindubusinessline
Shares of Deccan Gold Mines rallied as much as 17.3 per cent on hopes of a positive verdict from the Supreme Court on Hutti gold mines.
512068 DECNGOLD

 
Will Deccan Gold glitter on apex court verdict?

2018-05-07 thehindubusinessline
Shares of Deccan Gold Mines will remain in focus on Tuesday, as the Supreme Court will pronounce a verdict on Hutti gold mines. The company’s Hutti-Maski belt project, which hosts the Hutti gold deposit, is under dispute with Hutti Gold Mines Company to retain its legal rights for mining. If the Deccan Gold Mines gets an unfavourable verdict from the apex court, the stock will crash as it has rose sharply in the last few days.
512068 DECNGOLD

 
Company news: Deccan Exploration Services

2018-04-30 thehindubusinessline
Deccan Exploration Services Private Ltd, a subsidiary of Deccan Gold Mines, has paid ₹682 crore (inclusive of 10 per cent of processing fee) to Karnataka Industrial Areas Development Board (KIADB).
512068 DECNGOLD

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...